COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy.
Saved in:
| Title: | COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy. |
|---|---|
| Authors: | Gill J; Baylor University Medical Center at Dallas, 3500 Gaston Avenue, Barnett Tower, Ste 904, Dallas, TX, 75246, USA. Gilljasmeet30@gmail.com., Hebert CA; Division of Nephrology, Baylor University Medical Center at Dallas, Dallas, USA., Colbert GB; Division of Nephrology, Baylor University Medical Center at Dallas, Dallas, USA. |
| Source: | Journal of nephrology [J Nephrol] 2022 Jan; Vol. 35 (1), pp. 317-321. Date of Electronic Publication: 2021 Aug 24. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Italy NLM ID: 9012268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6059 (Electronic) Linking ISSN: 11218428 NLM ISO Abbreviation: J Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
